Graf Akcie MD (MEDNAX Inc). Diskuze k akciím MD. Aktuální informace MD.

Základní informace o společnosti MEDNAX Inc (Akcie MD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.28B
Hodnota podniku (EV) 3.02B
Tržby 1.797B
EBITDA 177.458M
Zisk -52.69
Růst v tržbách Q/Q -7.12 %
Růst v tržbách Y/Y -42.94 %
P/E (Cena vůči ziskům) N/A
Forward P/E 2.93
EV/Sales 1.68
EV/EBITDA 17.03
EV/EBIT 58.87
PEG 1.73
Price/Sales 1.27
P/FCF 23.64
Price/Book 3.06
Účetní hodnota na akcii 8.62
Hotovost na akcii 14.18
FCF vůči ceně 5.70 %
Počet zaměstnanců 5,600
Tržba na zaměstnance 320.889k
Profit margin -45.93 %
Operating margin 7.17 %
Gross margin 25.91 %
EBIT margin 2.86 %
EBITDA margin 9.88 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 28.13 %
EPS - Očekávaný růst příští rok 10.81 %
Return on assets -1.78 %
Return on equity -6.74 %
ROIC -17.86 %
ROCE 2.33 %
Dluhy/Equity 3.48
Čistý dluh/EBITDA 18.64
Current ratio 2.14
Quick Ratio 2.14
Volatilita 2.96
Beta 0.86
RSI 24.87
Cílová cena analytiků 19
Známka akcie (dle analytiků) 3.08
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 86.307M
Procento shortovaných akcií 13.01 %
Short ratio 9.47 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2003
Země United States

Finanční výsledky akcie MD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,733.951$1,779.759$1,723.107$3,253.391$3,183.159$2,779.996
Cost Of Goods Sold$1,284.63$1,276.67$1,218.146$2,333.779$2,149.636$1,851.985
Gross Profit$449.321$503.089$504.961$919.612$1,033.523$928.011
Research And Development Expenses------
SG&A Expenses$248.947$244.512$232.218$385.864$372.572$305.915
Other Operating Income Or Expenses------
Operating Expenses$1,635.819$1,608.003$1,474.719$2,798.499$2,611.472$2,222.128
Operating Income$98.132$171.756$248.388$454.892$571.687$557.868
Total Non-Operating Income/Expense$-90.984$-112.972$-82.18$-69.219$-57.888$-18.139
Pre-Tax Income$7.148$58.784$166.208$385.673$513.799$539.729
Income Taxes$16.728$16.576$44.694$80.231$189.203$204.038
Income After Taxes$-9.58$42.208$121.514$305.442$324.596$335.691
Other Income------
Income From Continuous Operations$-9.58$42.208$121.514$305.442$324.596$335.691
Income From Discontinued Operations$-786.908$-1,539.91$147.115$14.93--
Net Income$-796.488$-1,497.702$268.629$320.372$324.914$336.32
EBITDA$133.736$203.359$277.315$539.262$665.767$623.637
EBIT$98.132$171.756$248.388$454.892$571.687$557.868
Basic Shares Outstanding838391929293
Shares Outstanding838492939394
Basic EPS$-9.55$-17.94$2.95$3.47$3.52$3.61
EPS - Earnings Per Share$-9.55$-17.83$2.93$3.45$3.49$3.58
# 2020 2019 2018 2017 2016 2015
Current Ratio3.48691.35011.31271.18031.30781.2309
Long-term Debt / Capital0.69970.53580.390.37650.37880.3412
Debt/Equity Ratio2.33351.15430.63940.60420.61780.5229
Gross Margin25.913128.267329.305328.266332.468533.3817
Operating Margin5.65949.650514.415113.982117.959720.0672
EBIT Margin5.65949.650514.415113.982117.959720.0672
EBITDA Margin7.712811.426216.093916.575420.915322.433
Pre-Tax Profit Margin0.41223.30299.645811.854516.141219.4147
Net Profit Margin-45.9349-84.15215.58989.847310.207312.0979
Asset Turnover0.51790.42930.29020.55450.59620.6114
Inventory Turnover Ratio------
Receiveable Turnover7.16714.09833.40056.45526.4276.2509
Days Sales In Receivables50.926989.061107.337456.54456.791358.3918
ROE - Return On Equity-1.28122.81583.93529.960811.757513.77
Return On Tangible Equity1.2657-447.0636-9.4437-16.4443-18.5175-24.8196
ROA - Return On Assets-0.28611.01812.04665.20596.07937.3823
ROI - Return On Investment-0.38471.30712.40046.21097.30359.0711
Book Value Per Share8.735717.792735.161532.71929.458226.0067
Operating Cash Flow Per Share-1.80430.8334-2.07670.7350.8422-0.3072
Free Cash Flow Per Share-1.92010.7909-1.98230.87540.7086-0.4145